Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Lixte Biotechnology Holdings, Inc. (LIXT) had Free Cash Flow per Share of $-1.41 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-3.59M |
|
-- |
|
-- |
|
$3.57M |
|
$-3.57M |
|
$-0.01M |
|
$-3.59M |
|
$-3.59M |
|
$-3.59M |
|
$-3.59M |
|
$-3.59M |
|
$-3.59M |
|
$-3.57M |
|
$-3.57M |
|
2.25M |
|
2.25M |
|
$-1.59 |
|
$-1.59 |
|
| Balance Sheet Financials | |
$1.15M |
|
-- |
|
-- |
|
$1.15M |
|
$0.32M |
|
-- |
|
-- |
|
$0.32M |
|
$-2.67M |
|
$0.83M |
|
$0.83M |
|
2.25M |
|
| Cash Flow Statement Financials | |
$-3.16M |
|
-- |
|
-- |
|
$4.20M |
|
$1.04M |
|
$-3.16M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
134.17% |
|
-433.50% |
|
-313.05% |
|
-433.50% |
|
$0.37 |
|
|
Free Cash Flow per Share |
$-1.41 |
$-1.41 |
|